Recent Updates
Recently added Catalysts
NAUT Positive Sentiment

Nautilus Biotechnology to Participate in the TD Cowen 45th Annual Healthcare Conference

Key Takeaway: Nautilus Biotechnology, Inc. is set to participate in the TD Cowen 45th Annual Healthcare Conference. Scheduled for March 3, 2025, management will take part in a fireside chat, which can be accessed through the company website. The participation highlights Nautilus' advancements in the field of proteomics and its commitment to improving human health.
Price reaction · baseline $1.71 (2025-02-14 close) · hit after-hours · 1 other NAUT headline(s) in the window, move may be shared
day 0 close
0%

Market Sentiment Analysis

POSITIVE FACTORS

  • Nautilus is participating in a prestigious healthcare conference.
  • Their technology aims to transform proteomics and human health.
  • Management's engagement demonstrates commitment to transparency and investor relations.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Cash runway
~29 mo
Minimal dilution risk
Lead asset
MDMA
Phase 2 · Post-Traumatic Stress Disorder

Full Press Release Details

SEATTLE, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced the company will be participating in the TD Cowen 45th Annual Healthcare Conference.
Nautilus’ management is scheduled to participate in a fireside chat on Monday, March 3, 2025, at 1:50 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at: www.nautilus.bio.
About Nautilus Biotechnology, Inc.
With its corporate headquarters in Seattle and its research and development headquarters in the San Francisco Bay Area, Nautilus is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus’ mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. To learn more about Nautilus, visit www.nautilus.bio.

Frequently Asked Questions

What conference will Nautilus participate in?

Nautilus will participate in the TD Cowen 45th Annual Healthcare Conference.

When is Nautilus' fireside chat scheduled?

The fireside chat is set for March 3, 2025, at 1:50 p.m. Eastern Time.

Where can I access Nautilus' presentation webcasts?

Presentations can be accessed on the 'Investors' section of Nautilus' website.

What is the mission of Nautilus Biotechnology?

Nautilus aims to democratize access to the proteome to advance human health.

Where are Nautilus' headquarters located?

Nautilus has corporate headquarters in Seattle and R&D in the San Francisco Bay Area.

Last updated: Feb 18, 2025